Friday 6 November 2026
Export PACS’s income statement to Excel — free account
PACS Group, Inc.
PACS Healthcare Medical Care Facilities
PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.
- Revenue
- +11.5%
- EPS
- +16.4%
- Free cash flow
- −4.31%
- Total debt
- +7.48%
Quarter to September 2026, against a year earlier
49.17
1.03
−2.05%
Follow PACS
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 8 | 6 | 6 |
| 22.96% | 27.11% | 27.92% | 26.49% | ||
| 3.54% | 4.37% | 4.82% | 4.81% | ||
ROIC |
17.52% | 21.93% | 21.42% | 19.25% | |
Return on Tangible Assets |
15.09% | 18.71% | 20.63% | 22.83% | |
Average Days of Receivables |
48.45 | 49.27 | 47.60 | 47.99 | |
Free Cash Flow per Share |
1.92 | 2.43 | 2.89 | 2.83 | |
Free Cash Flow |
299.57 | 381.55 | 456.53 | 448.48 | |
Capital Expenditures |
(104.65) | (108.77) | (116.72) | (131.21) | |
| Other line items | |||||
Cash ROIC |
19.99% | 24.10% | 29.92% | 27.92% | |
Accounts Receivable Turnover |
7.46 | 7.37 | 7.85 | 7.90 | |
Accounts Payable Turnover |
24.55 | 24.05 | 27.82 | 24.71 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
15.56 | 14.46 | 12.68 | 13.68 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.33) | (0.31) | (0.30) | (0.30) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
7.85% | 7.89% | 7.97% | 8.39% | |
Share Based Compensation of Revenue |
1.02% | 1.15% | 1.34% | 1.88% | |
Interest Coverage |
10.92 | 13.68 | 13.88 | 16.21 | |
Operating CF/Net income |
2.11 | 2.01 | 2.13 | 2.09 | |
Depreciation/Fixed assets |
0.05 | 0.05 | 0.05 | 0.05 | |
Capex/Depreciation |
(1.78) | (1.69) | (1.64) | (1.71) | |
Revenue per Share |
33.86 | 34.58 | 35.11 | 36.02 | |
Operating CF per Share |
2.59 | 3.12 | 3.63 | 3.66 | |
Capex per Share |
(0.67) | (0.69) | (0.74) | (0.83) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 5 Nov 2026